Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 160, Issue 6, Pages 1550-1560
Publisher
Wiley
Online
2010-04-23
DOI
10.1111/j.1476-5381.2010.00809.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protection of dystrophic muscle cells with polyphenols from green tea correlates with improved glutathione balance and increased expression of 67LR, a receptor for (−)-epigallocatechin gallate
- (2009) Olivier M. Dorchies et al. BIOFACTORS
- Imatinib attenuates skeletal muscle dystrophy in mdx mice
- (2009) Ping Huang et al. FASEB JOURNAL
- Loss of positive allosteric interactions between neuronal nitric oxide synthase and phosphofructokinase contributes to defects in glycolysis and increased fatigability in muscular dystrophy
- (2009) M. Wehling-Henricks et al. HUMAN MOLECULAR GENETICS
- Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: outcome of a large array of in vivo and ex vivo tests
- (2009) Rosa Burdi et al. JOURNAL OF APPLIED PHYSIOLOGY
- Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy
- (2009) Yi Lai et al. JOURNAL OF CLINICAL INVESTIGATION
- Diagnosis and new treatments in muscular dystrophies
- (2009) A Y Manzur et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Nitric oxide generated by muscle corrects defects in hippocampal neurogenesis and neural differentiation caused by muscular dystrophy
- (2009) Bo Deng et al. JOURNAL OF PHYSIOLOGY-LONDON
- Development of a Nitric Oxide-Releasing Analogue of the Muscle Relaxant Guaifenesin for Skeletal Muscle Satellite Cell Myogenesis
- (2009) Guqi Wang et al. MOLECULAR PHARMACEUTICS
- MALDI reveals membrane lipid profile reversion in MDX mice
- (2009) Farida Benabdellah et al. NEUROBIOLOGY OF DISEASE
- Nitric oxide and repair of skeletal muscle injury
- (2009) Lidiane Isabel Filippin et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- l-Arginine Decreases Inflammation and Modulates the Nuclear Factor-κB/Matrix Metalloproteinase Cascade in Mdx Muscle Fibers
- (2008) Karim Hnia et al. AMERICAN JOURNAL OF PATHOLOGY
- Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy
- (2008) J Reutenauer et al. BRITISH JOURNAL OF PHARMACOLOGY
- Sarcolemma-localized nNOS is required to maintain activity after mild exercise
- (2008) Yvonne M. Kobayashi et al. NATURE
- Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment
- (2008) Hannah G. Radley et al. NEUROMUSCULAR DISORDERS
- Approaching a new age in Duchenne muscular dystrophy treatment
- (2008) Kathryn R. Wagner Neurotherapeutics
- Functional Deficits in nNOSμ-Deficient Skeletal Muscle: Myopathy in nNOS Knockout Mice
- (2008) Justin M. Percival et al. PLoS One
- HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment
- (2008) C. Colussi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nitric oxide reverses prednisolone-induced inactivation of muscle satellite cells
- (2007) Jenna L. Betters et al. MUSCLE & NERVE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now